Dexamethasone Treatment for OSA in Children

Summary

This is a double-blinded clinical trial of children diagnosed with moderate to severe obstructive sleep apnea (OSA) on a baseline polysomnogram (PSG). Participants will receive a 3-day course of dexamethasone, an oral steroid, or placebo control and undergo two PSGs to assess the efficacy of dexamethasone, as a treatment to manage the severity and symptoms in children with moderate to severe OSA.

Timeline

Start

2022-10-26

Primary completion

2024-07-21

Completion

2025-12-30

Drugs

Indications